Jinge Zhao
Overview
Explore the profile of Jinge Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
504
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao J, Tang B, Shen P, Zeng H, Wei Q
Crit Rev Oncol Hematol
. 2025 Mar;
:104698.
PMID: 40089046
Poly (ADP-ribose) polymerase (PARP) inhibitors have revolutionized the treatment of many cancers. Metastatic castration-resistant prostate cancer (mCRPC) is an area where PARP inhibitors are intensively studied; the efficacy with PARP...
2.
Liu H, Liu H, Chen J, Yin X, Zhu S, Hu X, et al.
Mod Pathol
. 2025 Mar;
:100748.
PMID: 40057038
TFE3-rearranged renal cell carcinoma (TFE3-RCC) is a rare but aggressive subtype of kidney cancer that mainly affects young patients. However, the molecular characteristics of TFE3-RCCs in children and adolescents remain...
3.
Shi Y, Wei X, Zhao F, Chen J, Sun G, Zhang X, et al.
Prostate
. 2025 Mar;
:e24869.
PMID: 40035401
Background: The prognostic value of the prostate adenocarcinoma (PAC) with ductal feature in patients with advanced prostate cancer treated with abiraterone acetate has not been scrutinized. This study aims to...
4.
He S, Zhao J, Chen J, Liang J, Hu X, Zhang X, et al.
Infect Drug Resist
. 2025 Jan;
18():209-226.
PMID: 39816240
Monkeypox (mpox), caused by mpox virus (MPXV) infection, reemerged in 2022 and still raises concerns globally. Abundant clinical data indicate that mpox is a sexually transmitted infection and that the...
5.
Wang Q, Zhang X, Zhu Q, Zeng H, Dai J, Chen J, et al.
Int Urol Nephrol
. 2024 Dec;
PMID: 39718702
Purpose: To evaluate the efficacy and safety of extended immunotherapy in first-line immune checkpoint inhibitors (ICIs)-tyrosine kinase inhibitors (TKIs) combination treatment for advanced renal cell carcinoma (RCC). Patients And Methods:...
6.
Zhao J, Chen J, Sun G, Shen P, Zeng H
Cancer Biol Med
. 2024 Dec;
21(11).
PMID: 39718161
Prostate cancer is a leading cause of cancer-related death in men worldwide. Luteinizing hormone-releasing hormone receptor (LHRH-R) agonists and antagonists are known to achieve castration-level testosterone suppression; however, long-term data...
7.
Zhang L, Wang X, Zhao J, Qi Y, Han K, Yu Y, et al.
Nano Lett
. 2024 Nov;
24(48):15396-15405.
PMID: 39539148
The dynamic nature of noncovalent bonds in peptide self-assembly allows for selective accommodation of guest molecules. However, it remains unclear how to harness coassembly to reinforce the host peptides and...
8.
Zhang L, Zhao J, Ma B, Wang X, Zhang J, Wang W
Chembiochem
. 2024 Nov;
26(3):e202400753.
PMID: 39533708
Designing molecules for multivalent targeting of specific disease markers can enhance binding stability which is critical in molecular imaging and targeted therapy. Through rational molecular design, the nanostructures formed by...
9.
Zhang L, Wang X, Zhao J, Sun B, Wang W
Chem Biomed Imaging
. 2024 Oct;
2(4):233-249.
PMID: 39473775
Molecular imaging was developed from basic molecular recognition. It can visualize not only the expression levels of specific molecules in a living system but also specific biological processes, thus providing...
10.
Wei X, Zhao J, Nie L, Shi Y, Zhao F, Shen Y, et al.
Prostate
. 2024 Oct;
85(2):130-139.
PMID: 39465570
Background: This study explored the value of intraductal carcinoma of the prostate (IDC-P) in predicting the efficacy of abiraterone treatment in metastatic hormone-sensitive prostate cancer (mHSPC) patients. Methods: A retrospective...